Hancock Jaffe

$6.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.28 (+4.80%) As of 5:55 PM UTC today

Why Robinhood?

You can buy or sell Hancock Jaffe and other stocks, options, and ETFs commission-free!

About HJLI

Hancock Jaffe Laboratories, Inc. Common Stock, also called Hancock Jaffe, is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease.

CEO
Robert Andrew Berman
Employees
19
Headquarters
Irvine, California
Founded
1999
Market Cap
51.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
398.68K
High Today
$6.10
Low Today
$5.85
Open Price
$5.85
Volume
71.64K
52 Week High
$20.25
52 Week Low
$5.55

HJLI Earnings

-$3.83
-$2.55
-$1.28
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 7, After Hours

You May Also Like

KIDS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure